Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 280 | 241 | 360 | 1,247 | 1,423 |
| TOTAL | $280 | $241 | $360 | $1,247 | $1,423 |
| Non-Current Assets | |||||
| PPE Net | 3,950 | 4,816 | 5,462 | 5,551 | 5,009 |
| Other Non-Current Assets | 11,620 | 1,509 | 1,552 | 1,739 | 128 |
| TOTAL | $15,570 | $6,325 | $7,014 | $7,290 | $5,137 |
| Total Assets | $15,850 | $6,566 | $7,374 | $8,537 | $6,560 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 1,824 | 2,213 | 2,641 | 0 |
| Accounts payable and accrued liabilities | 5,870 | 5,338 | 6,385 | 6,371 | 10,712 |
| Other current liabilities | 1,730 | 0 | 0 | 0 | 0 |
| TOTAL | $7,600 | $7,162 | $8,598 | $9,012 | $10,712 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 10,170 | 1,855 | 3,275 | 0 | 0 |
| TOTAL | $10,170 | $1,855 | $3,275 | $4,310 | $192 |
| Total Liabilities | $17,770 | $9,017 | $11,873 | $13,322 | $10,904 |
| Shareholders' Equity | |||||
| Common Shares | 510 | 511 | 460 | 247 | 213 |
| Other shareholders' equity | 0 | -5 | 34 | 0 | 0 |
| TOTAL | $298,720 | $285,033 | $253,616 | $162,188 | $146,745 |
| Total Liabilities And Equity | $316,490 | $294,050 | $265,489 | $175,510 | $157,649 |